{
    "clinical_study": {
        "@rank": "142769", 
        "arm_group": [
            {
                "arm_group_label": "Women with gestational diabetes", 
                "description": "Women with  gestational diabetes diagnosed by clinically routine 75 g oral glucose tolerance testing"
            }, 
            {
                "arm_group_label": "Women without  gestational diabetes", 
                "description": "Women without  gestational diabetes diagnosed by clinically routine 75 g oral glucose tolerance testing"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of the study is to investigate the effect of stress on glucose tolerance\n      during pregnancy.\n\n      The main objectives of the study are to investigate if various measures of stress (stressful\n      life events, the perceived level of stress and the cortisol or copeptin concentrations)\n      differ between pregnant women with and without gestational diabetes during the end of the\n      second/beginning of the third trimester when presenting for their routine glucose tolerance\n      testing.\n\n      Secondary objectives are the link between these different stress measures and the routinely\n      measured fasting and stimulated glucose levels during the oral glucose tolerance test."
        }, 
        "brief_title": "Effects of Stress on Glucose Tolerance During Pregnancy", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pregnancy", 
            "Stress", 
            "Gestational Diabetes"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes, Gestational"
            ]
        }, 
        "detailed_description": {
            "textblock": "Hypotheses in this study, 3 primary hypotheses will be tested.\n\n        1. Women with gestational diabetes have more life events compared to pregnant women\n           without gestational diabetes.\n\n        2. Women with gestational diabetes have higher perceived level of stress and anxiety\n           compared to pregnant women without gestational diabetes.\n\n        3. Women with gestational diabetes have higher measures of cortisol levels in the saliva\n           and in the nailfolds and higher plasma copeptin levels compared to pregnant women\n           without gestational diabetes.\n\n      Secondary objectives:\n\n      1. To test the link between these stress measures and the fasting and stimulated glucose\n      levels during the oral glucose tolerance test."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All pregnant women who are undergoing a 75 g oral glucose tolerance test at the\n             \"Maternit\u00e9\" of CHUV at 24-30 weeks of gestation between October 2012 and April 2013\n\n        Exclusion Criteria:\n\n          -  Pregnant woman who has the use if medications that influence either the cortisol and\n             /or the glucose levels\n\n          -  Pregnant woman who has the inability to fill out the questionnaires with assistance"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Pregnant women"
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01707784", 
            "org_study_id": "295/12"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pregnancy", 
            "Stress", 
            "Anxiety", 
            "Cortisol", 
            "Copeptin", 
            "Gestational diabetes"
        ], 
        "lastchanged_date": "April 18, 2013", 
        "location": {
            "contact": {
                "email": "jardena.puder@chuv.ch", 
                "last_name": "Jardena J Puder, MD", 
                "phone": "+41-21-314 06 38"
            }, 
            "facility": {
                "address": {
                    "city": "Lausanne", 
                    "country": "Switzerland", 
                    "zip": "1011"
                }, 
                "name": "Maternit\u00e9 CHUV, University of Lausanne"
            }, 
            "investigator": {
                "last_name": "Jardena J Puder, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_groups": "2", 
        "official_title": "Effects of Stress on Glucose Tolerance During Pregnancy", 
        "overall_official": [
            {
                "affiliation": "University of Lausanne", 
                "last_name": "Jardena J. Puder, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "University of Lausanne", 
                "last_name": "Ji-Seon Kang", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Lausanne", 
                "last_name": "Yvan Vial, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Z\u00fcrich", 
                "last_name": "Pr Ulrike Ehlert, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Lausanne", 
                "last_name": "Ayala Borghini, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Lausanne", 
                "last_name": "Pedro Marques-Vidal, MD, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Switzerland: Ethical committee of the canton Vaud", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "stress (stressful life events, the perceived level of stress and the cortisol or copeptin concentrations)", 
            "measure": "Markers of stress", 
            "safety_issue": "No", 
            "time_frame": "At assessment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01707784"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Lausanne Hospitals", 
            "investigator_full_name": "Jardena Puder", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Lausanne Hospitals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Lausanne Hospitals", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}